AstraZeneca’s Soliris given EU CHMP recommendation for marketing authorisation
26th June 2023 Uncategorised 0The authorisation would include certain patients with refractory generalised myasthenia gravis More: AstraZeneca’s Soliris given EU CHMP recommendation for marketing authorisation Source: News
read more